Interference with the Autophagic Process as a Viral Strategy to Escape from the Immune Control: Lesson from Gamma Herpesviruses

by Roberta Santarelli, Marisa Granato, Alberto Faggioni, Mara Cirone
Published 2015-01-01

Targeting of Prosurvival Pathways as Therapeutic Approaches against Primary Effusion Lymphomas: Past, Present, and Future

by Marisa Granato, Roberta Santarelli, Roberta Gonnella, Antonella Farina, Pankaj Trivedi, Alberto Faggioni, Mara Cirone
Published 2015-01-01

Autophagy manipulation as a strategy for efficient anticancer therapies: possible consequences

by Mara Cirone, Maria Saveria Gilardini Montani, Marisa Granato, Alessia Garufi, Alberto Faggioni, Gabriella D’Orazi
Published 2019-06-01

Apigenin, by activating p53 and inhibiting STAT3, modulates the balance between pro-apoptotic and pro-survival pathways to induce PEL cell death

by Marisa Granato, Maria Saveria Gilardini Montani, Roberta Santarelli, Gabriella D’Orazi, Alberto Faggioni, Mara Cirone
Published 2017-11-01

Cytotoxic Drugs Activate KSHV Lytic Cycle in Latently Infected PEL Cells by Inducing a Moderate ROS Increase Controlled by HSF1, NRF2 and p62/SQSTM1

by Marisa Granato, Maria Saveria Gilardini Montani, Camilla Angiolillo, Gabriella D’Orazi, Alberto Faggioni, Mara Cirone
Published 2018-12-01

Mutant p53, Stabilized by Its Interplay with HSP90, Activates a Positive Feed-Back Loop Between NRF2 and p62 that Induces Chemo-Resistance to Apigenin in Pancreatic Cancer Cells

by Maria Saveria Gilardini Montani, Nives Cecere, Marisa Granato, Maria Anele Romeo, Luca Falcinelli, Umberto Ciciarelli, Gabriella D’Orazi, Alberto Faggioni, Mara Cirone
Published 2019-05-01

Quercetin Interrupts the Positive Feedback Loop Between STAT3 and IL-6, Promotes Autophagy, and Reduces ROS, Preventing EBV-Driven B Cell Immortalization

by Marisa Granato, Maria Saveria Gilardini Montani, Claudia Zompetta, Roberta Santarelli, Roberta Gonnella, Maria Anele Romeo, Gabriella D’Orazi, Alberto Faggioni, Mara Cirone
Published 2019-09-01

JNK and macroautophagy activation by bortezomib has a pro-survival effect in primary effusion lymphoma cells.

by Marisa Granato, Roberta Santarelli, Lavinia V Lotti, Livia Di Renzo, Roberta Gonnella, Alessia Garufi, Pankaj Trivedi, Luigi Frati, Gabriella D'Orazi, Alberto Faggioni, Mara Cirone
Published 2013-01-01